MARKET

PMD

PMD

Psychemedics Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.36
+0.06
+0.87%
Opening 12:31 05/26 EDT
OPEN
6.31
PREV CLOSE
6.30
HIGH
6.36
LOW
6.31
VOLUME
634
TURNOVER
3.31K
52 WEEK HIGH
8.90
52 WEEK LOW
6.01
MARKET CAP
35.53M
P/E (TTM)
-49.2636
1D
5D
1M
3M
1Y
5Y
Psychemedics raises dividend by 40% to $0.07
Psychemedics (PMD) declares $0.07/share quarterly dividend, 40% increase from prior dividend of $0.05. Forward yield 4.56% Payable June 24; for shareholders of record May 27; ex-div May 26. See PMD
Seekingalpha · 05/10 21:57
Psychemedics GAAP EPS of $0.01, revenue of $6.5M
Psychemedics press release (NASDAQ:PMD): Q1 GAAP EPS of $0.01. Revenue of $6.5M (+14.0% Y/Y).
Seekingalpha · 05/10 21:48
BRIEF-Psychemedics Reports First Quarter 2022 Results And Increases Cash Dividend
reuters.com · 05/10 21:16
BRIEF-Peter Kamin Engaged With Psychemedics' Board On Nomination Of Three Candidates Including Himself - SEC Filing
reuters.com · 05/10 21:11
Psychemedics' Q1 Earnings Unchanged as Revenue Rises
MT Newswires · 05/10 17:29
-- Earnings Flash (PMD) PSYCHEMEDICS CORPORATION Reports Q1 Revenue $6.5M
MT Newswires · 05/10 17:15
Peter Kamin of Psychemedics Corporation (NASDAQ:PMD) Just Spent US$112k On Shares
Investors who take an interest in Psychemedics Corporation ( NASDAQ:PMD ) should definitely note that insider Peter...
Simply Wall St. · 04/08 15:32
Psychemedics GAAP EPS of -$0.29, revenue of $6.44M
Psychemedics press release (NASDAQ:PMD): Q4 GAAP EPS of -$0.29. Revenue of $6.44M (+20.6% Y/Y).
Seekingalpha · 03/29 21:24
More
No Data
Learn about the latest financial forecast of PMD. Analyze the recent business situations of Psychemedics Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
Actual
Estimate
-0.20-0.11-0.020.07
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Institutional Holdings
Institutions: 46
Institutional Holdings: 2.09M
% Owned: 37.31%
Shares Outstanding: 5.59M
TypeInstitutionsShares
Increased
4
2.26K
New
3
113.05K
Decreased
10
44.18K
Sold Out
6
100.55K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+2.69%
Healthcare Providers & Services
+1.57%
Key Executives
Chairman/Director/President/Chief Executive Officer
Raymond Kubacki
Executive Vice President
Charles Doucot
Vice President - Operations
Michael Schaffer
Vice President/Controller
Andrew Limbek
Independent Director
Robyn Davis
Independent Director
Andrew Reynolds
Independent Director
Walter Tomenson
Independent Director
Fred Weinert
No Data
No Data
About PMD
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customize its enzyme immunoassay (EIA) procedures to drug test hair samples. The Company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines, opiates, synthetic cannabinoids, benzodiazepines, nicotine and fentanyl. The Company’s testing process is used by police departments, Federal Reserve Banks, schools, and other public entities

Webull offers kinds of Psychemedics Corp. stock information, including NASDAQ:PMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PMD stock methods without spending real money on the virtual paper trading platform.